Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-14-147870
Filing Date
2014-04-17
Accepted
2014-04-17 17:05:27
Documents
3
Effectiveness Date
2014-04-17

Document Format Files

Seq Description Document Type Size
1 DEFA14A d711436ddefa14a.htm DEFA14A 42300
2 GRAPHIC g711436imge001.jpg GRAPHIC 6909
3 GRAPHIC g711436imge002.jpg GRAPHIC 2555
  Complete submission text file 0001193125-14-147870.txt   56954
Mailing Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487
Business Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487 561-961-1911
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-00100 | Film No.: 14770660
SIC: 2834 Pharmaceutical Preparations